Trending Topic

< 1 min

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

This corrects the article: “Ioannou A. Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis. Heart International. 2024;18(1):30-37”. Two typography errors were included incorrectly due to an editorial error. In Table 1, “eplontersen” was incorrectly written as “eplomtersen”. This has been corrected in the text. In the section “Eplontersen”, the administration schedule should be written as […]

Riyaz Bashir, TCT 2022: The Bashir endovascular catheter in patients with acute intermediate risk pulmonary embolism, the RESCUE study

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 29th 2022

The RESCUE study examined the Bashir endovascular catheter in patients with acute intermediate risk pulmonary embolism (PE). In this touchCARDIO interview, we speak with Dr Riyaz Bashir (Temple University Hospital, Philadelphia, PA, USA) to discuss the RESCUE study and future plans.

The abstract entitled ‘A Prospective Multicenter Trial of Pharmaco-Mechanical Catheter-Directed Thrombolysis With the BASHIR™ Endovascular Catheter for Intermediate-Risk Acute Pulmonary Embolism – The RESCUE Study’ was presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 16 – 19, September 2022.

Questions:

  1. What were the aims, design and eligibility criteria of the RESCUE study? (0:23)
  2. What were the efficacy and safety findings of the study? (2:06)
  3. What questions remain unanswered regarding the use of this catheter, and what further studies are planned? (3:17)

Disclosures: Riyaz Bashir is on the advisory board and speaker’s bureau for Thrombolex Inc. and a consultant for the company. He has received honorarium and grant/research support from Thrombolex Inc. and is a major stock shareholder.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.

Filmed as a highlight of TCT 2022

Access more content on Devices here

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup